Hemostatic Complications in Renal Transplantation

被引:6
作者
Poli, Daniela [1 ]
Antonucci, Emilia [2 ]
Zanazzi, Maria [3 ]
机构
[1] Azienda Osped Univ Careggi, Thrombosis Ctr, Viale Morgagni 85, I-50134 Florence, Italy
[2] Arianna Anticoagulaz Fdn, Clin Study Sect, Bologna, Italy
[3] Azienda Osped Univ Careggi, Renal Unit, Florence, Italy
关键词
renal transplantation; venous thromboembolism; bleeding; thromboprophylaxis; SURGICAL COMPLICATIONS; RISK-FACTORS; SINGLE-CENTER; THROMBOTIC COMPLICATIONS; ANTITHROMBOTIC THERAPY; VEIN THROMBOSIS; KIDNEY; RECIPIENTS; ANTICOAGULATION; THROMBOPHILIA;
D O I
10.1055/s-0037-1603364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) represents the irreversible loss of the excretory and homeostatic functions of the kidney. Renal transplantation is the preferred treatment for patients with advanced CKD. Despite the availability of more effective immunosuppressive drugs and the improvements in surgical techniques, the development of complications can compromise early and long-term outcomes of renal transplantation. In particular, bleeding and thrombotic disorders can have impact on patient and graft survival. Risk stratification, early diagnosis, and appropriate interventions are critical to the management of these complications. Renal arterial and vein thrombosis are the most common vascular complications in the early phase after transplantation, whereas renal artery stenosis is a late event mainly related to surgery. Standard heparin thromboprophylaxis should be adopted in the perioperative period. Among renal transplant recipients, a high risk of venous thromboembolism (VTE) is reported. This risk persists long after transplantation, and patients with a previous episode of VTE are also at high risk for recurrence. An extended anticoagulant treatment should be considered, balancing the bleeding risk in a given patient. To date, the use of vitamin K antagonists remains preferred, given the risk of pharmacological interference with immunosuppressive agents and the renal metabolism of direct oral anticoagulants. In this review, bleeding and thrombotic complications of renal transplantation are described, and recommended thromboprophylaxis is discussed.
引用
收藏
页码:742 / 749
页数:8
相关论文
共 54 条
  • [1] Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States
    Abbott, KC
    Cruess, DF
    Agodoa, LYC
    Sawyers, ES
    Tveit, DP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) : 120 - 130
  • [2] Abualhassan N, 2015, SAUDI J KIDNEY DIS T, V26, P1
  • [3] Kidney and haemostasis A (personal) time-journey
    Andrassy, K.
    [J]. HAMOSTASEOLOGIE, 2015, 35 (01): : 73 - 76
  • [4] Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years - Association with mortality and decline of glomerular filtration rate
    Astrup, Anne Sofie
    Tarnow, Lise
    Pietraszek, Lotte
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    Parving, Hans-Henrik
    Rossing, Peter
    [J]. DIABETES CARE, 2008, 31 (06) : 1170 - 1176
  • [5] Transplant renal artery stenosis
    Bruno, S
    Remuzzi, G
    Ruggenenti, P
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : 134 - 141
  • [6] US Renal Data System 2012 Annual Data Report
    Collins, Allan J.
    Foley, Robert N.
    Herzog, Charles
    Chavers, Blanche
    Gilbertson, David
    Herzog, Charles
    Ishani, Areef
    Johansen, Kirsten
    Kasiske, Bertram
    Kutner, Nancy
    Liu, Jiannong
    St. Peter, Wendy
    Ding, Shu
    Guo, Haifeng
    Kats, Allyson
    Lamb, Kenneth
    Li, Shuling
    Li, Suying
    Roberts, Tricia
    Skeans, Melissa
    Snyder, Jon
    Solid, Craig
    Thompson, Bryn
    Weinhandl, Eric
    Xiong, Hui
    Yusef, Akeem
    Zaun, David
    Arko, Cheryl
    Chen, Shu-Cheng
    Daniels, Frank
    Ebben, James
    Frazier, Eric
    Hanzlik, Christopher
    Johnson, Roger
    Sheets, Daniel
    Wang, Xinyue
    Forrest, Beth
    Constantini, Edward
    Everson, Susan
    Eggers, Paul
    Agodoa, Lawrence
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (01) : E1 - E459
  • [7] Vascular Complications in Renal Transplantation: A Single-Center Experience in 1367 Renal Transplantations and Review of the Literature
    Dimitroulis, D.
    Bokos, J.
    Zavos, G.
    Nikiteas, N.
    Karidis, N. P.
    Katsaronis, P.
    Kostakis, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1609 - 1614
  • [8] Perioperative Management of Antithrombotic Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
    Douketis, James D.
    Spyropoulos, Alex C.
    Spencer, Frederick A.
    Mayr, Michael
    Jaffer, Amir K.
    Eckman, Mark H.
    Dunn, Andrew S.
    Kunz, Regina
    [J]. CHEST, 2012, 141 (02) : E326S - E350S
  • [9] Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
    Ducloux, D
    Pellet, E
    Fournier, V
    Rebibou, JM
    Bresson-Vautrin, C
    Racadot, E
    Fellmann, D
    Chalopin, JM
    [J]. TRANSPLANTATION, 1999, 67 (01) : 90 - 93
  • [10] KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
    Eckardt, Kai-Uwe
    Kasiske, Bertram L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : S1 - S155